» Articles » PMID: 19021838

Subcortical Vascular Versus Amnestic Mild Cognitive Impairment: Comparison of Cerebral Glucose Metabolism

Overview
Journal J Neuroimaging
Publisher Wiley
Specialties Neurology
Radiology
Date 2008 Nov 22
PMID 19021838
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Most studies on mild cognitive impairment (MCI) have been focused on amnestic MCI (aMCI) that is the preclinical stage of Alzheimer's disease (AD). In contrast, only a few studies have involved patients in the preclinical stages of subcortical vascular dementia (subcortical vascular MCI, svMCI). We tried to compare the overall glucose metabolism in patients with svMCI with that of patients with aMCI.

Methods: We compared the regional metabolic patterns shown on 18 F-FDG (fluro deoxy glucose) positron emission tomography (PET) images from 18 patients with svMCI with those from 25 aMCI patients matched for age, sex, education, and mini-mental state examination (MMSE) score and with those from 35 healthy subjects using a voxel-wise analysis. SPM 2 was used for statistical analysis.

Results: Relative to normal controls, the hypometabolic regions in the aMCI patients were in the bilateral parahippocampal, bilateral posterior cingulate, left superior temporal gyri, left inferior parietal lobule, and right inferior frontal gyrus while those in the svMCI patients were located in the thalamus, insula, superior temporal gyrus, anterior cingulate gyrus, cingulum, right basal ganglia, cerebellum, and brainstem. A direct comparison of glucose metabolism between svMCI and aMCI showed that the glucose hypometabolism in patients with svMCI was more severe in the thalamus, brainstem, and cerebellum.

Conclusion: Our study suggested that svMCI was distinct from aMCI in terms of neuropsychological and PET findings, which may explain their clinical manifestations.

Citing Articles

Disruptive and complementary effects of depression symptoms on spontaneous brain activity in the subcortical vascular mild cognitive impairment.

Hu L, Chen J, Li X, Zhang H, Zhang J, Lu Y Front Aging Neurosci. 2024; 16:1338179.

PMID: 39355540 PMC: 11442267. DOI: 10.3389/fnagi.2024.1338179.


Heterogeneity of factors associated with cognitive decline and cortical atrophy in early- versus late-onset Alzheimer's disease.

Cho J, Yoon C, Shin J, Seo H, Kim W, Na H Sci Rep. 2024; 14(1):20429.

PMID: 39227668 PMC: 11372067. DOI: 10.1038/s41598-024-71402-6.


Effect of polycyclic aromatic hydrocarbon exposure on amnestic mild cognitive impairment and Alzheimer's disease: A matched case-control study.

Jang H, Sohn J, Kim H, Seo S, Noh Y, Koh S Heliyon. 2024; 10(15):e35614.

PMID: 39165972 PMC: 11334906. DOI: 10.1016/j.heliyon.2024.e35614.


Correlation of brain tissue volume loss with inflammatory biomarkers IL1β, P-tau, T-tau, and NLPR3 in the aging cognitively impaired population.

Lee K, Kim S, Tian Y, Jung S, Chang Y, Rhee H Front Aging Neurosci. 2024; 16:1388654.

PMID: 39109268 PMC: 11300291. DOI: 10.3389/fnagi.2024.1388654.


Distinct spatiotemporal patterns of cortical thinning in Alzheimer's disease-type cognitive impairment and subcortical vascular cognitive impairment.

Kim J, Kim J, Park Y, Yoo H, Kim J, Jang H Commun Biol. 2024; 7(1):198.

PMID: 38368479 PMC: 10874406. DOI: 10.1038/s42003-024-05787-5.